Fingerprint
Dive into the research topics of 'Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): A highly active regimen for advanced and poor-prognosis Hodgkin's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): A highly active regimen for advanced and poor-prognosis Hodgkin's disease
Peter H. Wiernik, Janice P. Dutcher, Avi I. Einzig, Joseph Sparano, Martin Frank, William Friedenberg
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations